series-b
Stage
2024
Founded
1
Investors
About
GondolaBio is a clinical-stage biopharmaceutical company developing therapeutics for genetic diseases, focusing on early-stage research and development of treatments for rare genetic conditions such as erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP).
Explore GondolaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.